Mount Sinai grad student, 25, named to Forbes '30 Under 30' in Science and Healthcare

December 20, 2012

Jillian Shapiro, a third-year graduate student at the Icahn School of Medicine at Mount Sinai, has been named to the second annual Forbes "30 Under 30" list in "Science and Health." The honorees "reflect the way that the health care landscape is transforming for the better, opening up to revolutionary new ideas and new approaches," according to the editors of Forbes.

Ms. Shapiro, 25, a native of Rochester, New York, discovered a new molecular pathway that can be used to deliver () into cells that could have significant implications in the development of future therapeutics across disease types. Present technology uses nuclear viruses that cause a number of problems such as genome integration and bottlenecking of nuclear export that can be averted by Ms. Shapiro's method. Equally important, the research reveals a way to produce very high levels of the desired small RNAs without impacting the normal small RNA profile.

Her discovery was so significant that her thesis committee granted her permission to defend her PhD after only two years instead of the normal five, but she has decided to continue in the lab until her final paper is accepted, likely in the Spring of 2013.

"Being named to the Forbes list is such an extraordinary honor," said Ms. Shapiro. "It is incredibly rewarding to have all of my hard work and dedication to research recognized in such a prestigious fashion, especially as a graduate student."

Ms. Shapiro participated in the Summer Undergraduate Research Program (SURP), a fellowship offered by the Icahn School of Medicine at Mount Sinai, the summer after her junior year at New York University. She stayed on in the lab during her senior year performing research full time while simultaneously finishing her undergraduate degree. Following her graduation, she officially joined the lab of Benjamin tenOever, PhD, Irene and Arthur Fishberg Professor of Medicine.

"I am delighted that Forbes recognizes the significance of Jillian Shapiro's research and the amazing accomplishment of having achieved this success by the age of 25," said Dr. tenOever. "I am incredibly proud of Jillian for these achievements and have no doubt that she will continue producing this type of paradigm-shifting research. This recognition is very well deserved and speaks volumes to the strength of Mount Sinai and the Department of Microbiology."

Dr. tenOever's lab broadly focuses on the molecular interactions between viruses and their host. The overall objective of this lab is to gain a thorough understanding of the molecular basis of virus disease in an effort to generate improved vaccines and therapeutics, something Jillian's research embodies.

Ms. Shapiro has already published two first-author papers in and two second-author papers, in Cell Host and Microbe and Molecular Therapy and is working on her third first-author paper.

Explore further: Researchers approaching universal treatment for all strains of influenza

Related Stories

Lineage trees reveal cells' histories

February 23, 2012

In recent years, a number of controversial claims have been made about the female mammal's egg supply – that it is renewed over her adult lifetime (as opposed to the conventional understanding that she is born with all ...

Scientists deepen genetic understanding of MS

October 25, 2012

(Medical Xpress)—Five scientists, including two from Simon Fraser University, have discovered that 30 per cent of our likelihood of developing Multiple Sclerosis (MS) can be explained by 475,806 genetic variants in our ...

Recommended for you

Basic research fuels advanced discovery

August 26, 2016

Clinical trials and translational medicine have certainly given people hope and rapid pathways to cures for some of mankind's most troublesome diseases, but now is not the time to overlook the power of basic research, says ...

New method creates endless supply of kidney precursor cells

August 25, 2016

Salk Institute scientists have discovered the holy grail of endless youthfulness—at least when it comes to one type of human kidney precursor cell. Previous attempts to maintain cultures of the so-called nephron progenitor ...

New avenue for understanding cause of common diseases

August 25, 2016

A ground-breaking Auckland study could lead to discoveries about many common diseases such as diabetes, cancer and dementia. The new finding could also illuminate the broader role of the enigmatic mitochondria in human development.

Strict diet combats rare progeria aging disorders

August 25, 2016

Mice with a severe aging disease live three times longer if they eat thirty percent less. Moreover, they age much healthier than mice that eat as much as they want. These are findings of a joint study being published today ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.